Atieh Givmanesh

Scientist II


PSM in biotechnology, University of San Francisco; B.S. in biotechnology, University of California Davis

Previous Experience:

Prior to insitro, I worked at IDEAYA Biosciences and was responsible for developing and leading the in vitro IND-enabling studies for IDE397, a small molecule inhibitor targeting methionine adenosyltransferase 2a (MAT2A), currently being evaluated in an ongoing Phase 1/2 clinical trial.

Responsibilities at insitro:

As a member of the POSH team in Advanced Cellular Technologies group, I contribute to the advancement of our pooled optical screening platform by developing microscopy-based phenotypic assays and scalable predictive disease models.